Turmeric Extract - LONGVIDA® Optimized

Turmeric Extract - LONGVIDA® Optimized is a Botanical supplement available in 1 form.

Not all forms of Turmeric Extract - LONGVIDA® Optimized are equal. The form you choose determines how much Turmeric Extract - LONGVIDA® Optimized actually reaches your tissues, and the difference between the best and worst forms can be substantial. LONGVIDA is the only curcumin form clinically demonstrated to cross the blood-brain barrier, delivering free (unconjugated) curcumin to brain tissue. Standard curcumin and even enhanced forms like C3+BioPerine primarily elevate blood curcumin levels without confirmed CNS penetration.

Turmeric Extract - LONGVIDA® Optimized (from Curcuma longa root) Preferred (Preferred Form) has a bioavailability rating of high (S1 — best tier). Typical dose range: not yet documented in our database.

Longvida (Solid Lipid Curcumin Particle) technology encapsulates free curcumin in a tri-lipid matrix, enabling plasma detection at doses where unformulated curcumin is undetectable. Review data indicates ~100-fold higher relative bioavailability vs standard curcumin. Recent crossover data (2025) clarifies the mechanism: absorption occurs primarily in the intestinal compartment, with low unconjugated plasma AUC but high fecal recovery relative to micellar forms like NovaSOL.

Healthy volunteers receiving 650mg SLCP (Longvida) achieved mean peak plasma curcumin of 22.43 ng/mL; unformulated curcumin extract at equivalent dose produced undetectable plasma levels. Human PK study in osteosarcoma patients and healthy volunteers. PMID: 20092313

Review of 11 curcumin formulations with human PK data: Longvida (SLCP) demonstrated approximately 100-fold higher bioavailability versus reference unformulated curcumin. Superior solubility and stability attributed to lipid matrix protecting curcumin through digestion. PMID: 30006023

Crossover study (n=9 healthy males) comparing Longvida, NovaSOL, and AOV at ~570mg curcumin: unconjugated plasma curcumin remained below 2nM across all formulations; high fecal recovery for Longvida/AOV vs NovaSOL suggests differing intestinal absorption and first-pass metabolism pathways. PMID: 40487425

Turmeric Extract - LONGVIDA® Optimized (from Curcuma longa root) is classified as Preferred Form by FormulaForge — our top recommendation for Turmeric Extract - LONGVIDA® Optimized. It carries a bioavailability rating of high (S1 — best tier), meaning more of the active compound reaches your tissues per dose unit compared to lower-rated forms.

When choosing a Turmeric Extract - LONGVIDA® Optimized supplement, look for the S1 (best absorption) bioavailability tier on the label. Preferred Forms have the strongest research-backed evidence for efficient absorption.

Other forms may be appropriate depending on individual goals, cost considerations, and your healthcare provider’s guidance. The best form for you depends on your specific health needs.

For Turmeric Extract - LONGVIDA® Optimized (from Curcuma longa root), the typical dosing range is not yet documented in our database. Individual dose requirements vary based on health goals, body weight, and existing nutrient intake.

Side Effects: Specific side effect data for these forms is not yet documented in our database. In general, consult your healthcare provider regarding tolerability at higher doses.

These statements are based on structure/function research and have not been evaluated by the FDA. This information is not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before starting or changing a supplement regimen.

The following studies and findings inform FormulaForge classifications for Turmeric Extract - LONGVIDA® Optimized:

Healthy volunteers receiving 650mg SLCP (Longvida) achieved mean peak plasma curcumin of 22.43 ng/mL; unformulated curcumin extract at equivalent dose produced undetectable plasma levels. Human PK study in osteosarcoma patients and healthy volunteers. PMID: 20092313

Review of 11 curcumin formulations with human PK data: Longvida (SLCP) demonstrated approximately 100-fold higher bioavailability versus reference unformulated curcumin. Superior solubility and stability attributed to lipid matrix protecting curcumin through digestion. PMID: 30006023

Crossover study (n=9 healthy males) comparing Longvida, NovaSOL, and AOV at ~570mg curcumin: unconjugated plasma curcumin remained below 2nM across all formulations; high fecal recovery for Longvida/AOV vs NovaSOL suggests differing intestinal absorption and first-pass metabolism pathways. PMID: 40487425